Altria Q3 EPS Beats; Shares Fall on Weak Outlook

Altria reported Q3 2025 adjusted EPS of $1.45, a 3.6% increase that beat estimates, while net revenues fell about 3% year‑over‑year to roughly $6.07 billion as smokable and oral product volumes declined. Management set 2025 adjusted EPS guidance of $5.37–$5.45 and expanded its share repurchase program to $2 billion. The company raised its quarterly dividend 3.9% to $1.06 and highlighted modest growth in ON! nicotine pouches and regulatory progress on heated tobacco, but said e‑vapor headwinds — including competitive flavored disposable products and an NJOY patent halt — weighed on volumes. Altria's Form 10‑Q showed lower net earnings and impairment charges that pressured profitability. Shares plunged more than 7% intraday and fell in subsequent sessions as investors digested the tepid outlook and persistent category challenges.